Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 471 entries
Sorted by: Best Match Show Resources per page
Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate?.

British journal of cancer

Clavel J, Sermage-Faure C, Demoury C, Rudant J, Goujon-Bellec S, Guyot-Goubin A, Deschamps F, Hémon D.
PMID: 23949156
Br J Cancer. 2013 Sep 03;109(5):1383-4. doi: 10.1038/bjc.2013.424. Epub 2013 Aug 15.

No abstract available.

Cite
Clavel J, Sermage-Faure C, Demoury C, et al. Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate?. Br J Cancer. 2013;109(5):1383-4doi: 10.1038/bjc.2013.424.
Clavel, J., Sermage-Faure, C., Demoury, C., Rudant, J., Goujon-Bellec, S., Guyot-Goubin, A., Deschamps, F., & Hémon, D. (2013). Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate?. British journal of cancer, 109(5), 1383-4. https://doi.org/10.1038/bjc.2013.424
Clavel, J, et al. "Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate?." British journal of cancer vol. 109,5 (2013): 1383-4. doi: https://doi.org/10.1038/bjc.2013.424
Clavel J, Sermage-Faure C, Demoury C, Rudant J, Goujon-Bellec S, Guyot-Goubin A, Deschamps F, Hémon D. Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate?. Br J Cancer. 2013 Sep 03;109(5):1383-4. doi: 10.1038/bjc.2013.424. Epub 2013 Aug 15. PMID: 23949156; PMCID: PMC3778284.
Copy Download .nbib Format: NLM
Inaccuracy and vested interests--two threats to etiologic research.

Leukemia

Hoffmann W, Straif S.
PMID: 10086749
Leukemia. 1999 Mar;13(3):495-7. doi: 10.1038/sj.leu.2401349.

No abstract available.

Cite
Hoffmann W, Straif S. Inaccuracy and vested interests--two threats to etiologic research. Leukemia. 1999;13(3):495-7doi: 10.1038/sj.leu.2401349.
Hoffmann, W., & Straif, S. (1999). Inaccuracy and vested interests--two threats to etiologic research. Leukemia, 13(3), 495-7. https://doi.org/10.1038/sj.leu.2401349
Hoffmann, W, and Straif, S. "Inaccuracy and vested interests--two threats to etiologic research." Leukemia vol. 13,3 (1999): 495-7. doi: https://doi.org/10.1038/sj.leu.2401349
Hoffmann W, Straif S. Inaccuracy and vested interests--two threats to etiologic research. Leukemia. 1999 Mar;13(3):495-7. doi: 10.1038/sj.leu.2401349. PMID: 10086749.
Copy Download .nbib Format: NLM
Lymphomas--troublesome problems in management.

CA: a cancer journal for clinicians

Rundles W.
PMID: 4210856
CA Cancer J Clin. 1974 May-Jun;24(3):137-40. doi: 10.3322/canjclin.24.3.137.
Free Article

No abstract available.

Cite
Rundles W. Lymphomas--troublesome problems in management. CA Cancer J Clin. 1974;24(3):137-40doi: 10.3322/canjclin.24.3.137.
Rundles, W. (1974). Lymphomas--troublesome problems in management. CA: a cancer journal for clinicians, 24(3), 137-40. https://doi.org/10.3322/canjclin.24.3.137
Rundles, W. "Lymphomas--troublesome problems in management." CA: a cancer journal for clinicians vol. 24,3 (1974): 137-40. doi: https://doi.org/10.3322/canjclin.24.3.137
Rundles W. Lymphomas--troublesome problems in management. CA Cancer J Clin. 1974 May-Jun;24(3):137-40. doi: 10.3322/canjclin.24.3.137. PMID: 4210856.
Copy Download .nbib Format: NLM
Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Moignet A, Lamy T.
PMID: 30231346
Am Soc Clin Oncol Educ Book. 2018 May 23;38:616-625. doi: 10.1200/EDBK_200689.

Large granular lymphocyte (LGL) leukemia has been recognized in the World Health Organization classifications among mature T cell and natural killer cell neoplasms and is divided into three categories. Chronic T cell leukemia and natural killer cell lymphocytosis can...

Cite
Moignet A, Lamy T. Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia. Am Soc Clin Oncol Educ Book. 2018;38:616-625doi: 10.1200/EDBK_200689.
Moignet, A., & Lamy, T. (2018). Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 38616-625. https://doi.org/10.1200/EDBK_200689
Moignet, Aline, and Lamy, Thierry. "Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia." American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting vol. 38 (2018): 616-625. doi: https://doi.org/10.1200/EDBK_200689
Moignet A, Lamy T. Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia. Am Soc Clin Oncol Educ Book. 2018 May 23;38:616-625. doi: 10.1200/EDBK_200689. PMID: 30231346.
Copy Download .nbib Format: NLM
Leukaemia prevalence worldwide: raising aetiology questions.

The Lancet. Haematology

Oliveira PD.
PMID: 29304323
Lancet Haematol. 2018 Jan;5(1):e2-e3. doi: 10.1016/S2352-3026(17)30231-4.

No abstract available.

Cite
Oliveira PD. Leukaemia prevalence worldwide: raising aetiology questions. Lancet Haematol. 2018;5(1):e2-e3doi: 10.1016/S2352-3026(17)30231-4.
Oliveira, P. D. (2018). Leukaemia prevalence worldwide: raising aetiology questions. The Lancet. Haematology, 5(1), e2-e3. https://doi.org/10.1016/S2352-3026(17)30231-4
Oliveira, Pedro Dantas. "Leukaemia prevalence worldwide: raising aetiology questions." The Lancet. Haematology vol. 5,1 (2018): e2-e3. doi: https://doi.org/10.1016/S2352-3026(17)30231-4
Oliveira PD. Leukaemia prevalence worldwide: raising aetiology questions. Lancet Haematol. 2018 Jan;5(1):e2-e3. doi: 10.1016/S2352-3026(17)30231-4. PMID: 29304323.
Copy Download .nbib Format: NLM
Advancing a field by building consortia: The example of the European LeukemiaNet.

Cancer

Hehlmann R.
PMID: 29451688
Cancer. 2018 Mar 15;124(6):1100-1104. doi: 10.1002/cncr.31199. Epub 2018 Feb 16.

No abstract available.

Cite
Hehlmann R. Advancing a field by building consortia: The example of the European LeukemiaNet. Cancer. 2018;124(6):1100-1104doi: 10.1002/cncr.31199.
Hehlmann, R. (2018). Advancing a field by building consortia: The example of the European LeukemiaNet. Cancer, 124(6), 1100-1104. https://doi.org/10.1002/cncr.31199
Hehlmann, Rüdiger. "Advancing a field by building consortia: The example of the European LeukemiaNet." Cancer vol. 124,6 (2018): 1100-1104. doi: https://doi.org/10.1002/cncr.31199
Hehlmann R. Advancing a field by building consortia: The example of the European LeukemiaNet. Cancer. 2018 Mar 15;124(6):1100-1104. doi: 10.1002/cncr.31199. Epub 2018 Feb 16. PMID: 29451688.
Copy Download .nbib Format: NLM
[No title available]

Therapeutische Umschau. Revue therapeutique

Passweg JR.
PMID: 32157968
Ther Umsch. 2019;76(9):469. doi: 10.1024/0040-5930/a001121.

No abstract available.

Cite
Passweg JR. Leukämien 2020: Ein Update. . Ther Umsch. 2019;76(9):469doi: 10.1024/0040-5930/a001121.
Passweg, J. R. (2019). Leukämien 2020: Ein Update. . Therapeutische Umschau. Revue therapeutique, 76(9), 469. https://doi.org/10.1024/0040-5930/a001121
Passweg, Jakob R. "Leukämien 2020: Ein Update." . Therapeutische Umschau. Revue therapeutique vol. 76,9 (2019): 469. doi: https://doi.org/10.1024/0040-5930/a001121
Passweg JR. Leukämien 2020: Ein Update. . Ther Umsch. 2019;76(9):469. doi: 10.1024/0040-5930/a001121. German. PMID: 32157968.
Copy Download .nbib Format: NLM
[Application and challenges of the new generation detection technologies in precision medicine for leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Qin YZ, Huang XJ.
PMID: 31207696
Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):353-357. doi: 10.3760/cma.j.issn.0253-2727.2019.05.001.

No abstract available.

Cite
Qin YZ, Huang XJ. [Application and challenges of the new generation detection technologies in precision medicine for leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2019;40(5):353-357doi: 10.3760/cma.j.issn.0253-2727.2019.05.001.
Qin, Y. Z., & Huang, X. J. (2019). [Application and challenges of the new generation detection technologies in precision medicine for leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 40(5), 353-357. https://doi.org/10.3760/cma.j.issn.0253-2727.2019.05.001
Qin, Y Z, and Huang, X J. "[Application and challenges of the new generation detection technologies in precision medicine for leukemia]." Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi vol. 40,5 (2019): 353-357. doi: https://doi.org/10.3760/cma.j.issn.0253-2727.2019.05.001
Qin YZ, Huang XJ. [Application and challenges of the new generation detection technologies in precision medicine for leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):353-357. doi: 10.3760/cma.j.issn.0253-2727.2019.05.001. Chinese. PMID: 31207696; PMCID: PMC7342227.
Copy Download .nbib Format: NLM
Aligning EHR Data for Pediatric Leukemia With Standard Protocol Therapy.

JCO clinical cancer informatics

Wood NM, Davis S, Lewing K, Noel-MacDonnell J, Glynn EF, Caragea D, Hoffman MA.
PMID: 33656914
JCO Clin Cancer Inform. 2021 Mar;5:239-251. doi: 10.1200/CCI.20.00144.

PURPOSE: Children with acute lymphoblastic leukemia (ALL) are treated according to risk-based protocols defined by the Children's Oncology Group (COG). Alignment between real-world clinical practice and protocol milestones is not widely understood. Aggregate deidentified electronic health record (EHR) data...

Cite
Wood NM, Davis S, Lewing K, et al. Aligning EHR Data for Pediatric Leukemia With Standard Protocol Therapy. JCO Clin Cancer Inform. 2021;5:239-251doi: 10.1200/CCI.20.00144.
Wood, N. M., Davis, S., Lewing, K., Noel-MacDonnell, J., Glynn, E. F., Caragea, D., & Hoffman, M. A. (2021). Aligning EHR Data for Pediatric Leukemia With Standard Protocol Therapy. JCO clinical cancer informatics, 5239-251. https://doi.org/10.1200/CCI.20.00144
Wood, Nicole M, et al. "Aligning EHR Data for Pediatric Leukemia With Standard Protocol Therapy." JCO clinical cancer informatics vol. 5 (2021): 239-251. doi: https://doi.org/10.1200/CCI.20.00144
Wood NM, Davis S, Lewing K, Noel-MacDonnell J, Glynn EF, Caragea D, Hoffman MA. Aligning EHR Data for Pediatric Leukemia With Standard Protocol Therapy. JCO Clin Cancer Inform. 2021 Mar;5:239-251. doi: 10.1200/CCI.20.00144. PMID: 33656914; PMCID: PMC8140784.
Copy Download .nbib Format: NLM
Electric power consumption and leukaemia death rate in Japan.

Lancet (London, England)

Sokejima S, Kagamimori S, Tatsumura T.
PMID: 8813998
Lancet. 1996 Sep 21;348(9030):821-2. doi: 10.1016/S0140-6736(05)65237-3.

No abstract available.

Cite
Sokejima S, Kagamimori S, Tatsumura T. Electric power consumption and leukaemia death rate in Japan. Lancet. 1996;348(9030):821-2doi: 10.1016/S0140-6736(05)65237-3.
Sokejima, S., Kagamimori, S., & Tatsumura, T. (1996). Electric power consumption and leukaemia death rate in Japan. Lancet (London, England), 348(9030), 821-2. https://doi.org/10.1016/S0140-6736(05)65237-3
Sokejima, S, et al. "Electric power consumption and leukaemia death rate in Japan." Lancet (London, England) vol. 348,9030 (1996): 821-2. doi: https://doi.org/10.1016/S0140-6736(05)65237-3
Sokejima S, Kagamimori S, Tatsumura T. Electric power consumption and leukaemia death rate in Japan. Lancet. 1996 Sep 21;348(9030):821-2. doi: 10.1016/S0140-6736(05)65237-3. PMID: 8813998.
Copy Download .nbib Format: NLM
EMF exposure study rules out 'causing' cancer, finds 'association' with leukemia puzzling but real.

JAMA

Marwick C.
PMID: 8940305
JAMA. 1996 Dec 04;276(21):1705-6.

No abstract available.

Cite
Marwick C. EMF exposure study rules out 'causing' cancer, finds 'association' with leukemia puzzling but real. JAMA. 1996;276(21):1705-6
Marwick, C. (1996). EMF exposure study rules out 'causing' cancer, finds 'association' with leukemia puzzling but real. JAMA, 276(21), 1705-6.
Marwick, C. "EMF exposure study rules out 'causing' cancer, finds 'association' with leukemia puzzling but real." JAMA vol. 276,21 (1996): 1705-6.
Marwick C. EMF exposure study rules out 'causing' cancer, finds 'association' with leukemia puzzling but real. JAMA. 1996 Dec 04;276(21):1705-6. PMID: 8940305.
Copy Download .nbib Format: NLM
On the pathogenesis of human leukaemia.

Acta haematologica

Viderbaek A.
PMID: 4959895
Acta Haematol. 1966;36(3):183-97. doi: 10.1159/000209099.

No abstract available.

Cite
Viderbaek A. On the pathogenesis of human leukaemia. Acta Haematol. 1966;36(3):183-97doi: 10.1159/000209099.
Viderbaek, A. (1966). On the pathogenesis of human leukaemia. Acta haematologica, 36(3), 183-97. https://doi.org/10.1159/000209099
Viderbaek, A. "On the pathogenesis of human leukaemia." Acta haematologica vol. 36,3 (1966): 183-97. doi: https://doi.org/10.1159/000209099
Viderbaek A. On the pathogenesis of human leukaemia. Acta Haematol. 1966;36(3):183-97. doi: 10.1159/000209099. PMID: 4959895.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 471 entries